To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Biomet price tag grows to $11.4bn
Days before a scheduled shareholder vote, Blackstone, KKR, Goldman and TPG have amended their agreement to buy Biomet, increasing the deal for the orthopedic products manufacturer by nearly 5 percent.
